DMRA
Damora TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
DMRA vs peer average
74/100
DMRA vs. peer average (B vs. C)
Grade spread
A 1 · B 1 · C 4 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CING is the first available peer comparator.
Cingulate fits mainly as a micro-cap development-stage volatility benchmark with dependence on execution milestones and capital markets access.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
DMRA
Damora Therapeutics
CING
Cingulate
Grade
B
D
Momentum
81
5
Value
42
41
Sentiment
56
100
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs CING
DMRA / CING
Grade Position
Above peers
DMRA vs. peer average (B vs. C)
74/100
Momentum
81
DMRAValue
42
DMRASentiment
56
CINGRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs DMRA
CING is the first peer returned for this comparison set.